definiens: means all laboratory notebooks in UCL ’s possession, custody or control which emanate from laboratories at UCL, inso far as they concern or contain information relating to any of the Programs, Program IP, Materials or UCL Background IP ; means one of the BCMA Licence, [ * * * ] Licence ( if [COMPANY] exercises its rights under Clause 2.4 ), GD2 Licence, Logic Gate Licence, NSG Licence, RQR8 Licence, TRBC1/2 Licence, ZipCAR Licence, ccCAR Licence, iCAR Licence, Epitope Tag Licence, Retrostim Licence, RapaiCASP9 Licence, TetCAR Licence, ZAP - CAR Licence, CAT19 Licence, TRBC2 Dx Licence, CAT19 CNS Licence, Manufacturing Licence, the Background Licence and the licences granted under Clause 2.3 ; means the Original Licensed Patents, the Additional Licensed Patents, the CAT19 Patent Rights and the TRBC2 Dx PatentRights . For the avoidance of doubt, notwithstanding their assignment to [COMPANY] pursuant to the Patent Assignment, or subsequent assignment toan Assignee Entity, the Assigned Patents shall continue to be included within the definition of Licensed Patents ; has the meaning set out in Clause 11.1.1(ii ) ; has the meaning set out in Clause 2.2.4 ; means any product or therapy which is covered by, uses or incorporates any of the Logic Gate Program IP ; means the program of research deﬁned in Schedule 1 under the title Logic Gate Program as conducted prior to theEffective Date ; means, excluding Manufacturing Know - How, ( i ) those patent applications listed in Schedule 2 under the title LogicGate Patents and all Patent Rights derived therefrom ( ) ; ( ii ) the Know - How described in Schedule 2 under the titleLogic Gate Know - How ; ( iii ) the materials listed in Schedule 2 under the title Logic Gate Materials together with all IP in the same ; and ( iv ) allKnow - How and materials ( together with all IP in the same ) developed by MP and/or the MP Laboratory pursuant speciﬁcally to the Logic GateProgram prior to the Effective Date including the technology claimed or disclosed in the Logic Gate Patent Rights filed as of the Effective Date ( orthe Amendment Date for those Logic Gate Patents Rights ﬁled as of the Amendment Date ), other than that which is CGK as of the Eﬀective Date(or, in respect of those Logic Gate Patent Rights ﬁled as of the Amendment Date, the Amendment Date ) or disclosed in the sections of the LogicGate Patent Rights that refer to, describe or disclose prior art including CGK existing as of the Eﬀective Date or Amendment Date, as applicable, provided that to the extent that any materials in ( iii ) or ( iv ) incorporate any of the following binders, CD5, CD19, CD22, CD23, CD33 and / orEGFRvIII, such binders together with IP in the same are excluded . References to CGK in this deﬁnition shall exclude CGK that became CGKthrough disclosure after the Eﬀective Date by publication of the Logic Gate Patent Rights ( ﬁled as of the Eﬀective Date ), or by MP making apublication in accordance with this Agreement or by [COMPANY] ’ publication ; has the meaning set out in Clause 2.3 ; means that Know - How generated by each of [ * * * ] prior to the Eﬀective Date, irrespective of its use or applicationin any of the Programs, which is required for or beneﬁcial to practice any of the Program IP licensed hereunder, including that listed in Schedule4 ; or means an application for a Marketing Approval ; or means those Regulatory Approval(s ) required by applicable laws and regulations in a particular country orterritory in order to sell or commercially supply a medicinal product and/or device in that country or territory ; or means Dr Martin Pule of [ * * * ] for so long as he is employed by, consults for or otherwise holds any position at orundertakes or supervises any research at UCL or UCLB ; has the meaning set out in Clause 5.7 ; means Program Materials and Background Materials ; means a Success Milestone, an Additional Milestone or a Sales Milestone ; means a Success Milestone Payment, an Additional Milestone Payment, a Sales Milestone Payment, an Additional LGMilestone Payment or an Additional ZC Milestone Payment ; 9CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [ * * * ], HAS BEEN OMITTED BECAUSE IT IS NOTMATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED